OKYO — OKYO PHARMA LTD
As of Q2 2026, 5 SEC-registered investment managers reported holding OKYO (OKYO PHARMA LTD) in their latest 13F filings, with a combined reported value of $988.36K across 658.90K shares. That is +0.3% by share count (+2.25K shares) versus the previous quarter, while reported value moved -6.5%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions, 2 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
OKYO is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Balyasny Asset Management history | 580.60K | $870.89K | 0.00% | Reduce |
| UBS Group AG history | 55.01K | $82.51K | 0.00% | Reduce |
| Geode Capital Management history | 12.09K | $18.14K | 0.00% | Hold |
| Renaissance Technologies history | 11.20K | $16.80K | 0.00% | New |
| Morgan Stanley history | 10 | $15 | 0.00% | Hold |
Q1 2026 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Balyasny Asset Management history | 584.80K | $941.52K | 0.00% | New |
| UBS Group AG history | 59.76K | $96.21K | 0.00% | Add |
| Geode Capital Management history | 12.09K | $19.46K | 0.00% | Hold |
| Morgan Stanley history | 10 | $16 | 0.00% | Hold |
Q4 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Renaissance Technologies history | 138.00K | $285.66K | 0.00% | Add |
| Geode Capital Management history | 12.09K | $25.03K | 0.00% | Hold |
| UBS Group AG history | 2.17K | $4.50K | 0.00% | New |
| Morgan Stanley history | 10 | $21 | 0.00% | New |
Q3 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Northern Trust Corp history | 57.16K | $114.32K | 0.00% | New |
| Renaissance Technologies history | 41.20K | $82.40K | 0.00% | New |
| Citadel Advisors history | 15.36K | $30.71K | 0.00% | New |
| Geode Capital Management history | 12.09K | $24.18K | 0.00% | Hold |
Q2 2025 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Geode Capital Management history | 12.09K | $31.07K | 0.00% | Hold |
| UBS Group AG history | 115 | $296 | 0.00% | New |
Q1 2025 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 27.40K | $34.80K | 0.00% | Add |
| Citadel Advisors history | 27.40K | $34.80K | 0.00% | Add |
| Renaissance Technologies history | 13.95K | $17.71K | 0.00% | Reduce |
| Renaissance Technologies history | 13.95K | $17.71K | 0.00% | Reduce |
| Geode Capital Management history | 12.09K | $15.35K | 0.00% | Hold |
New Positions (Q2 2026)
- Renaissance Technologies 11.20K sh · $16.80K
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 8 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balyasny Asset Management | 580.60K | 584.80K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 55.01K | 59.76K | 2.17K | — | 115 | — | 3.00K | 525 | 1.90K | — | — | 95 | — | 7.52K | 1.18K | 3.67K |
| Geode Capital Management | 12.09K | 12.09K | 12.09K | 12.09K | 12.09K | 12.09K | 12.09K | 12.09K | 12.09K | 12.09K | 12.09K | 12.09K | — | — | — | — |
| Renaissance Technologies | 11.20K | — | 138.00K | 41.20K | — | 13.95K | 16.50K | — | — | — | 11.80K | 16.35K | — | — | — | — |
| Morgan Stanley | 10 | 10 | 10 | — | — | — | — | — | — | — | 13.85K | 13.85K | — | — | — | — |
| Citadel Advisors | — | — | — | 15.36K | — | 27.40K | 20.73K | 14.88K | — | — | — | 15.94K | — | — | — | 26.86K |
| Northern Trust Corp | — | — | — | 57.16K | — | — | — | — | — | — | — | — | — | — | — | — |
| Goldman Sachs Group | — | — | — | — | — | — | — | — | — | — | — | — | 19.81K | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details